Javascript must be enabled for the correct page display
Skip to Content
navigation opener

BUILT FOR COMMERCIAL

engineered for scale

Commercial biologics manufacturing demands infrastructure, regulatory discipline, and operational precision. Bora Biologics offers a bi‑coastal, inspection‑proven U.S. biologics platform designed for commercialization from day one. Our integrated drug substance operations in San Diego, CA and Rockville, MD, supported by a development center of excellence in Zhubei, Taiwan, provide the foundation for reliable scale and licensed supply.

Together, our platform supports partners from development through commercial production — delivering the execution discipline required for durable commercial performance.

 20,000L U.S. single-use bioreactor capacity
  3 active commercial programs supplying 6 global markets
  200+ GMP batches executed
100% first-pass PPQ success
2 FDA-registered facilities specialized in late-stage production
1 integrated development center of excellence

EXPLORE how we do it

Advancing Biologics

one cell at a time

A technology-driven Contract Development and Manufacturing Organization (CDMO), Bora Biologics specializes in mammalian and microbial development and manufacturing. Our mission is to accelerate access to cutting-edge technologies and comprehensive manufacturing capabilities that empower our clients to transform the future of medicine. With a focus on collaboration, we are dedicated to advancing biologics one cell at a time.

image description image description image description image description

End-to-End CDMO Solutions

tailored to you

We adapt seamlessly to your needs, ensuring efficiency and cost savings at every stage of development and manufacturing. Your success is our priority.

clinical to commercial scale

mammalian & microbial expertise

DEVELOPMENT PROCESSES
MANUFACTURING & QUALITY ASSURANCE
MANAGEMENT & OPERATIONS

State-of-the-Art Facilities

from concept to commercialization

We leverage our state-of-the-art facilities and global presence to efficiently move your project from concept to commercialization.

Sorrento Valley, San Diego, CA, USA

Located in the heart of a leading U.S. biotech innovation hub, our FDA‑registered San Diego facility anchors Bora Biologics’ commercial drug substance operations. Equipped with advanced single‑use technology and supported by experienced manufacturing and quality teams, the site delivers reliable late‑stage and licensed supply for global markets.

East Coast Biotech Corridor, Rockville, MD, USA

Situated within the East Coast Biotech Corridor, our FDA‑registered Rockville facility expands Bora Biologics’ bi‑coastal U.S. manufacturing platform. Featuring large‑scale single‑use bioreactor capacity and integrated quality systems, the site supports development through commercial production with inspection‑proven infrastructure.

Hsinchu Biomedical Science Park, Zhubei City, Taiwan

Located in one of Taiwan’s fastest growing biomedical clusters, our Zhubei facility serves as Bora Biologics’ integrated development center of excellence. The cGMP site is built on scalable single‑use platform technology, advancing programs from early development through clinical supply to enable seamless transition to U.S. commercial manufacturing.

Discoveries

illuminating the path to
biologics excellence

Press Releases

Jul 3, 2026

Bora Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations for $122.5M

May 11, 2026

Bora Group to Acquire MacroGenics’ GMP Manufacturing Operations

Apr 3, 2026

Bora Biologics Successfully Completes 2,000L Engineering and Scale-Up Run in San Diego, Reinforcing Commercial-Scale Readiness

ALL PRESS
image description image description image description image description

Latest Publications

Building Commercial Certainty at 2,000L

Manufacturing in a Tariff-Driven World: Why Commercial Biologics Capacity Must Align with Market Demand

Bora Biologics: Commercialization as the New Competitive Filter

ALL PUBLICATIONS

Expert Insights

Advancing Biologics Tech Transfer: Operational Discipline for Late-Stage and Commercial Programs

Scaling Single‑Use Bioreactors & Facilities

From Asia to North America: A Seamless Path to Commercial

ALL INSIGHTS

Bora Biologics

the logical choice

Join the ranks of biopharma pioneers who trust us.
Explore how we minimize risks and accelerate your success.

Partner with us

Client-Centric

100% commitment to supporting your success

We have been the client, bringing multiple biologics from IND to BLA. Your needs and goals are at the forefront of our approach. By involving you in every step of the process, we ensure transparency and alignment, reducing the likelihood of misunderstandings and ensuring the outcome meets your expectations.

Experience

15 years developing & manufacturing biologics

We have honed our ability to navigate complexities. Our track record from concept to commercialization means we can apply best practices and lessons learned, ensuring smoother project execution.

Expertise

200 seasoned scientists & regulatory professionals

Our team exudes deep knowledge and specialized skills, with over 50% holding advanced degrees. This expertise allows us to foresee potential challenges and implement proactive solutions, reducing the likelihood of setbacks.

Commercial-Ready

Two US FDA registered GMP manufacturing facilities

We focus on delivering solutions that are ready for market. With clinical to commercial scale facilities consistently meeting compliance standards, we ensure your project is primed for success, minimizing the risk of costly revisions or delays.

Allied

access to global CDMO resources

Our partnership with Bora Pharmaceuticals provides additional resources and insights. This network enables us to leverage shared knowledge and expertise, further mitigating risks and accelerating the overall success of your project.